What are the treatment options for onychomycosis (toenail fungus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Terbinafine is the recommended first-line treatment for onychomycosis (toenail fungus) due to its higher efficacy and tolerability compared to other options, with a dosage of 250mg daily for 12-16 weeks. The treatment of onychomycosis depends on the severity of the infection, with topical antifungal medications like ciclopirox (Penlac) nail lacquer or efinaconazole (Jublia) and tavaborole (Kerydin) solutions being effective for mild to moderate cases 1. However, for more severe or resistant infections, oral medications like terbinafine, itraconazole, or fluconazole are more effective 1.

Some key points to consider when treating onychomycosis include:

  • Terbinafine has been shown to be superior to itraconazole in terms of efficacy and tolerability, with cure rates of 70-80% for toenail infections and 80-90% for fingernail infections 1.
  • Itraconazole is an alternative option, with a dosage of 200mg daily for 12 weeks continuously, or as pulse therapy at a dose of 400mg per day for 1 week per month 1.
  • Fluconazole may be a useful alternative in patients unable to tolerate terbinafine or itraconazole, with a dosage of 450mg per week for 3 months in fingernail infections and for at least 6 months in toenail infections 1.
  • Proper foot hygiene is essential during treatment, including keeping feet dry, wearing breathable shoes, changing socks daily, and avoiding walking barefoot in public areas.
  • Treatment success requires patience, as complete nail regrowth takes 6-18 months, and recurrence rates remain high (10-50%) without preventive measures.

It's also important to note that home remedies like vinegar soaks or over-the-counter options containing undecylenic acid may help with mild cases, but their effectiveness is not well established 1. Overall, the choice of treatment should be based on the severity of the infection, the patient's medical history, and the potential risks and benefits of each option.

From the FDA Drug Label

Terbinafine tablets, USP are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Ciclopirox Topical Solution, 8%, (Nail Lacquer), as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum

The treatment options for onychomycosis (toenail fungus) include:

  • Oral terbinafine: indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium) 2
  • Topical ciclopirox: indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum 3 Key considerations:
  • Prior to initiating treatment, appropriate nail specimens for laboratory testing should be obtained to confirm the diagnosis of onychomycosis 2
  • The comprehensive management program for topical ciclopirox includes removal of the unattached, infected nails as frequently as monthly, by a health care professional 3

From the Research

Treatment Options for Onychomycosis

Onychomycosis, also known as toenail fungus, can be treated using various modalities. The treatment options include:

  • Surgical methods
  • Chemical methods
  • Topical treatments
  • Oral treatments

Oral Treatments

Oral treatments for onychomycosis include:

  • Terbinafine: a fungicidal antifungal compound shown to be effective in the treatment of onychomycosis 4
  • Itraconazole: a systemic treatment approved by the US Food and Drug Administration 5
  • Griseofulvin: a systemic treatment approved by the US Food and Drug Administration 5
  • Fluconazole: a systemic therapy option for the treatment of onychomycosis 6

Topical Treatments

Topical treatments for onychomycosis include:

  • Efinaconazole 10% topical solution: an FDA-approved treatment for onychomycosis patients aged 6 years and above, which functions as an antifungal by disrupting ergosterol synthesis in the fungal cell membrane 7
  • Ciclopirox 8% nail lacquer: a topical treatment option for onychomycosis, which may be used alone or in combination with oral antifungal agents 8
  • Amorolfine 5% nail lacquer: a topical treatment option for onychomycosis, which may be used alone or in combination with oral antifungal agents 8
  • Tavaborole: a topical treatment option that has shown promise in phase III studies 6

Other Treatment Options

Other treatment options for onychomycosis include:

  • Laser systems: a treatment option for onychomycosis, although mechanical modalities are sometimes used but are seldom necessary 6
  • Combination therapy: using antifungal nail lacquers in combination with oral agents, such as terbinafine and itraconazole, can improve the efficacy of antifungal therapy 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapies for onychomycosis: a review.

Dermatologic clinics, 2006

Research

Current and emerging options in the treatment of onychomycosis.

Seminars in cutaneous medicine and surgery, 2013

Research

Efinaconazole in Onychomycosis.

American journal of clinical dermatology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.